Identification and validation of biomarkers for autism spectrum disorders

Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders, but effective medical treatments for the core symptoms of the disorder are still lacking. Genetic and preclinical approaches now provide unprecedented opportunities to identify the underpinning pathophysiological mechanisms and aetiology-based treatment targets. Eva Loth, Kings College London discusses.

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

European Autism Interventions - A Multicentre Study for Developing New Medications

Next Article

Entanglement: The Secret Lives of Hair

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×